Decoding hepatocarcinogenesis from a noncoding RNAs perspective
Journal of Cellular Physiology · 2023
DOI: 10.1002/jcp.31076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2023. Verfasst von Mostafa K Abd El-Aziz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 253 Literaturangaben.
Abstract (Originalsprache)
Being a leading lethal malignancy worldwide, the pathophysiology of hepatocellular carcinoma (HCC) has gained a lot of interest. Yet, underlying mechanistic basis of the liver tumorigenesis is poorly understood. The role of some coding genes and their respective translated proteins, then later on, some noncoding RNAs (ncRNAs) such as microRNAs have been extensively studied in context of HCC pathophysiology; however, the implication of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) in HCC is indeed less investigated. As a subclass of the ncRNAs which has been elusive for long time ago, lncRNAs was found to be involved in plentiful cellular functions such as DNA, RNA, and proteins regulation. Hence, it is undisputed that lncRNAs dysregulation profoundly contributes to HCC via diverse etiologies. Accordingly, lncRNAs represent a hot research topic that requires prime focus in HCC. In this review, the authors discuss breakthrough discoveries involving lncRNAs and circRNAs dysregulation that have contributed to the contemporary concepts of HCC pathophysiology and how these concepts could be leveraged as potential novel diagnostic and prognostic HCC biomarkers. Further, this review article sheds light on future trends, thereby discussing the pathological roles of lncRNAs and circRNAs in HCC proliferation, migration, and epithelial‐to‐mesenchymal transition. Along this line of reasoning, future recommendations of how these targets could be exploited to achieve effective HCC‐related drug development is highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.
- Molecular Genetics Research Team (MGRT), Biology and Biochemistry Department, School of Life and Medical Sciences, University of Hertfordshire Hosted by Global Academic Foundation, Cairo, Egypt.
- Molecular Genetics Research Team (MGRT), Pharmaceutical Biology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt.
- Chemistry Department, School of Life and Medical Sciences, University of Hertfordshire Hosted by Global Academic Foundation, Cairo, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
ORCID-Profile: Sherif Ashraf Fahmy, Nadia M Hamdy, Rana A Youness
Zitieren
APA
El-Aziz, M. K. A., Dawoud, A., Kiriacos, C. J., Fahmy, S. A., Hamdy, N. M., & Youness, R. A. (2023). Decoding hepatocarcinogenesis from a noncoding RNAs perspective. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31076
Vancouver
El-Aziz MKA, Dawoud A, Kiriacos CJ, Fahmy SA, Hamdy NM, Youness RA. Decoding hepatocarcinogenesis from a noncoding RNAs perspective. Journal of Cellular Physiology. 2023. doi:10.1002/jcp.31076
BibTeX
@article{ElAziz2023,
author = {El-Aziz, Mostafa K Abd and Dawoud, Alyaa and Kiriacos, Caroline J and Fahmy, Sherif Ashraf and Hamdy, Nadia M and Youness, Rana A},
title = {Decoding hepatocarcinogenesis from a noncoding RNAs perspective},
journal = {Journal of Cellular Physiology},
year = {2023},
doi = {10.1002/jcp.31076}
}
EUVIMED